Health technology assessment in middle-income countries: recommendations for a balanced assessment system
{{output}}
Because of significant differences in institutional contexts, health technology assessment (HTA) systems that are in place in core pharmaceutical markets may not be suitable, fully or in part, for middle-income countries (MICs) and for other noncore markets. P... ...
